Head of International Early Asset Strategy - Oncology

A global biopharmaceutical company is seeking an experienced leader to set oncology asset strategies, guiding evidence and market access approaches for cutting-edge therapies. The role requires deep oncology expertise, proven leadership in integrating science and commercial strategies, and driving decisions across diverse international markets. Ideal candidates will have advanced qualifications and be skilled in portraying clinical data, influencing evidence generation, and managing cross-functional collaborations. Join us to impact the launch of innovative oncology solutions.#J-18808-Ljbffr